Tag : ANTIMICROBIAL PEPTIDES

  • CONFERENCE UPDATE
    Identifying high-risk infants for AD through early skin microbiome and metabolome signatures: A sub-cohort analysis of the S-PRESTO study

    Early identification of high-risk infants for atopic dermatitis (AD) in the pre-disease stage can be crucial as it allows more well-timed and effective targeted intervention for AD prevention.1 During the 2024 AAAAI Annual Meeting, Dr. Elizabeth Tham from the National University of Singapore, presented the results of a sub-study within the Singapore Preconception Study of Long-Term Maternal and Child Outcomes (S-PRESTO), which aimed to identify signatures of early skin microbiome, natural moisturizing factors (NMFs) and anti-microbial peptides (AMPs) that can predict infantile AD at 6 and 18 months of life.